Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy
Recruitment status was: Not yet recruiting
A relationship between IBD and spondyloarthropathy is well recognized. ASCA ( anti saccharomyces cerevisiae antibodies)are considered to be a serological marker for Crohn's disease and have been studied in patients with spondyloarthropathy with conflicting results. More recently, new serological markers for IBD have been described. These markers are antibodies to certain defined glycans , and their use may permit an improved diagnosis of IBD.
The aim of our study is to investigate wether these new serological markers are present in the sera of patients with spondyloarthropathy.
|Psoriatic Arthritis Ankylosing Spondylitis Undifferentiated Spondyloarthropathy|
|Study Design:||Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Time Perspective: Prospective
Please refer to this study by its ClinicalTrials.gov identifier: NCT00517101
|Principal Investigator:||valerie aloush, MD||Tel-Aviv Sourasky Medical Center|